India stands at a defining moment in its life sciences journey. Having built formidable strengths across pharmaceuticals, vaccines, scientific research, and technology, the country now has an opportunity to move beyond capability creation towards innovation-led leadership. The next chapter will be shaped by India's ability to translate scientific discoveries into real-world impact, connect research with industry, leverage emerging technologies, and build the conditions that enable ideas to scale. Achieving this ambition will require deeper collaboration across academia, industry, government, investors, and innovators to accelerate the path from breakthrough science to transformative healthcare solutions. India can strengthen its innovation ecosystem while playing a leading role in shaping the future of global health.
It is against this backdrop that Lilly India, in partnership with FICCI, presents the inaugural Bharat Life Sciences Award (BLSA) 2026, a first-of-its-kind national platform scheduled for 1st October 2026 at Vigyan Bhawan, New Delhi.
